Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus

American Journal of Cardiology

Volumn 97, Issue 3, 2006, Pages 340-342

  Kaneda, Hideaki ^a   Ako, Junya ^a   Kataoka, Toru ^a   Takahashi, Takefumi ^a   Terashima, Mitsuyasu ^a   Waseda, Katsuhisa ^a   Miyazawa, Akiyoshi ^a   Hassan, Ali ^a   Honda, Yasuhiro ^a   Yock, Paul G ^a   Fitzgerald, Peter J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; CORONARY STENT; DIABETES MELLITUS; DIABETIC PATIENT; HUMAN; HYPERPLASIA; METAL IMPLANTATION; PRIORITY JOURNAL; RESTENOSIS; ULTRASOUND;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY VESSELS; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; STENTS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 31144462526     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.08.067     Document Type: Article

References (19)

1. K.H. Mak, D.P. Faxon Clinical studies on coronary revascularization in patients with type 2 diabetes Eur Heart J 24 2003 1087 1103
2. V. Mathew, B.J. Gersh, B.A. Williams, W.K. Laskey, J.T. Willerson, R.T. Tilbury, B.R. Davis, D.R. Holmes Jr Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial Circulation 109 2004 476 480
3. W.K. Laskey, F. Selzer, H.A. Vlachos, J. Johnston, A. Jacobs, S.B. King III, D.R. Holmes, J. Douglas, P. Block, R. Wilensky Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 90 2002 1062 1067
4. D. Aronson, Z. Bloomgarden, E.J. Rayfield Potential mechanisms promoting restenosis in diabetic patients J Am Coll Cardiol 27 1996 528 535
5. S.H. Park, S.P. Marso, Z. Zhou, F. Foroudi, E.J. Topol, A.M. Lincoff Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus Circulation 104 2001 815 819
6. R. Kornowski, G.S. Mintz, K.M. Kent, A.D. Pichard, L.F. Satler, T.A. Bucher, M.K. Hong, J.J. Popma, M.B. Leon Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study Circulation 95 1997 1366 1369
7. Y. Morino, H. Kaneda, T. Fox, A. Takagi, A.H. Hassan, R. Bonan, I. Crocker, A.J. Lansky, W.K. Laskey, M. Suntharalingam Delivered dose and vascular response after beta-radiation for in-stent restenosis retrospective dosimetry and volumetric intravascular ultrasound analysis Circulation 106 2002 2334 2339
8. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
9. G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessy, J.T. Mann, M. Turco, R. Caputo, P. Bergin, J. Greenberg A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
10. K.P. Morgan, A. Kapur, K.J. Beatt Anatomy of coronary disease in diabetic patients an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention Heart 90 2004 732 738
11. J.E. Sousa, A. Abizaid, G. Guagliumi, B. Lewis, R. Mehran, A. Lansky, S. Cohen, P.J. Fitzgerald, A. Chaves, L.A. Mattos Does the dose of sirolimus affect outcomes after drug-eluting stenting in diabetic patients? Final results of the Double Dose Diabetes (3D) study J Am Coll Cardiol 45 suppl 2005 74A
12. B.E. Sobel, J. Woodcock-Mitchell, D.J. Schneider, R.E. Holt, K. Marutsuka, H. Gold Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients a potential factor predisposing to thrombosis andf its persistence Circulation 97 1998 2213 2221
13. S. Elezi, A. Kastrati, J. Pache, A. Wehinger, M. Hadamitzky, J. Dirschinger, F.J. Neumann, A. Schomig Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement J Am Coll Cardiol 32 1998 1866 1873
14. J. Schofer, M. Schluter, T. Rau, F. Hammer, N. Haag, D.G. Mathey Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients a controlled study J Am Coll Cardiol 35 2000 1554 1559
15. E. Van Belle, R. Ketelers, C. Bauters, M. Perie, K. Abolmaali, F. Richard, J.M. Lablanche, E.P. McFadden, M.E. Bertrand Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up A key determinant of survival in diabetics after coronary balloon angioplasty Circulation 103 2001 1218 1224
16. S.J. Park, W.H. Shim, D.S. Ho, A.E. Raizner, S.W. Park, M.K. Hong, C.W. Lee, D. Choi, Y. Jang, R. Lam A paclitaxel-eluting stent for the prevention of coronary restenosis N Engl J Med 348 2003 1537 1545
17. R.A. Corpus, P.B. George, J.A. House, S.R. Dixon, S.C. Ajluni, W.H. Devlin, G.C. Timmis, M. Balasubramaniam, W.W. O'Neill Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention J Am Coll Cardiol 43 2004 8 14
18. C. Briguori, G. Condorelli, F. Airoldi, G.W. Mikhail, B. Ricciardelli, A. Colombo Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients Heart 90 2004 1481 1482
19. E.A. de Vrey, G.S. Mintz, C. von Birgelen, T. Kimura, M. Noboyoshi, J.J. Popma, P.W. Serruys, M.B. Leon Serial volumetric (three-dimensional) intravascular ultrasound analysis of restenosis after directional coronary atherectomy J Am Coll Cardiol 32 1998 1874 1880